Home LiteratureArticle Details
PMID: 8057456 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Mutations at palmitylation sites of the influenza virus hemagglutinin affect virus formation.

Journal of virology ·Vol. 68 ·No. 9 ·1994-09-00 ·Pages 5748-54

Zurcher T, Luo G, Palese P

Abstract

The carboxy terminus of the hemagglutinin (HA) of influenza A viruses contains three cysteine residues which are highly conserved among HA subtypes. It has previously been shown for the H2, H3, and H7 subtypes of HA that these cysteine residues are modified by the covalent attachment of palmitic acid. In order to study the role of the acylated cysteines in the formation of infectious influenza viruses, we introduced mutations into the HA of influenza A/WSN/33 virus (H1 subtype) by reverse-genetics techniques. We found that the cysteine at position 563 of the cytoplasmic tail is required for infectious-particle formation. The cysteine at position 560 can be changed to alanine or tyrosine to yield virus strains that are attenuated in cell cultures. The change from cysteine at position 553 to serine or alanine does not significantly alter the phenotype of the virus. The requirement for a cysteine at position 563 suggests a functional role for palmitylation of the cytoplasmic tail. This interpretation is further supported by experiments in which two or more of the cysteine residues were mutated, eliminating potential palmitylation sites. None of these double or triple mutations resulted in infectious virus. Selection of revertants of the attenuated cysteine-to-tyrosine mutant (mutation at position 560) always resulted in reversion to cysteine rather than to other amino acids. Although our data indicate a biological role for the conserved cysteine residues in the cytoplasmic tail of the HA of influenza viruses, we cannot exclude the possibility that structural constraints in the cytoplasmic tail of the HA--rather than altered palmitylation--are the determining factors for infectious-particle formation.

MeSH Terms
Amino Acid Sequence Animals Base Sequence Cell Line DNA Primers/chemistry Dogs Hemagglutinins, Viral/chemistry In Vitro Techniques Influenza A virus/growth & development Molecular Sequence Data Mutagenesis, Site-Directed Palmitates/metabolism Protein Processing, Post-Translational Sequence Alignment Sequence Homology, Amino Acid Structure-Activity Relationship Transfection
Chemicals
DNA Primers Hemagglutinins, Viral Palmitates
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Zurcher T
Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029.
Luo G
Palese P
References (29)
29 references, click to expand
  1. Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells.
    J Virol. 1977 Oct;24(1):170-6 PMID: 561860
  2. Palmitoylation of the influenza A virus M2 protein.
    Virology. 1990 Nov;179(1):51-6 PMID: 2219738
  3. Transformation of mammalian cells with an amplifiable dominant-acting gene.
    Proc Natl Acad Sci U S A. 1980 Jun;77(6):3567-70 PMID: 6251468
  4. Complete sequence analysis shows that the hemagglutinins of the H0 and H2 subtypes of human influenza virus are closely related.
    Virology. 1981 May;111(1):113-24 PMID: 7233828
  5. Structure of the influenza virus hemagglutinin.
    Curr Top Microbiol Immunol. 1981;94-95:1-74 PMID: 6171388
  6. Cerulenin blocks fatty acid acylation of glycoproteins and inhibits vesicular stomatitis and Sindbis virus particle formation.
    J Biol Chem. 1982 Sep 10;257(17):9887-90 PMID: 6286658
  7. Mutations in the cytoplasmic domain of the influenza virus hemagglutinin affect different stages of intracellular transport.
    J Cell Biol. 1985 Mar;100(3):704-14 PMID: 3972890
  8. On the structure of the acyl linkage and the function of fatty acyl chains in the influenza virus haemagglutinin and the glycoproteins of Semliki Forest virus.
    J Gen Virol. 1985 Dec;66 ( Pt 12):2635-47 PMID: 3934339
  9. Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus.
    Cell. 1986 Jan 17;44(1):147-58 PMID: 3000619
  10. Molecular characterization of a new hemagglutinin, subtype H14, of influenza A virus.
    Virology. 1990 Dec;179(2):759-67 PMID: 2238469
  11. Fatty acids on the A/Japan/305/57 influenza virus hemagglutinin have a role in membrane fusion.
    EMBO J. 1990 Dec;9(12):3857-66 PMID: 2249653
  12. Site-specific mutagenesis identifies three cysteine residues in the cytoplasmic tail as acylation sites of influenza virus hemagglutinin.
    J Virol. 1991 May;65(5):2491-500 PMID: 1901916
  13. High-efficiency formation of influenza virus transfectants.
    J Virol. 1991 May;65(5):2711-3 PMID: 2016777
  14. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses.
    Virology. 1991 Jun;182(2):475-85 PMID: 2024485
  15. Site-directed mutations in Sindbis virus E2 glycoprotein's cytoplasmic domain and the 6K protein lead to similar defects in virus assembly and budding.
    Virology. 1991 Jul;183(1):206-14 PMID: 1647069
  16. A single amino acid change in the cytoplasmic domain alters the polarized delivery of influenza virus hemagglutinin.
    J Cell Biol. 1991 Aug;114(3):413-21 PMID: 1860878
  17. Deacylation of the hemagglutinin of influenza A/Aichi/2/68 has no effect on membrane fusion properties.
    Virology. 1991 Sep;184(1):445-8 PMID: 1871979
  18. Mechanism of attenuation of a chimeric influenza A/B transfectant virus.
    J Virol. 1992 Aug;66(8):4679-85 PMID: 1629948
  19. Effects of altering palmitylation sites on biosynthesis and function of the influenza virus hemagglutinin.
    J Virol. 1992 Dec;66(12):7585-8 PMID: 1433532
  20. Role of acylation of viral haemagglutinin during the influenza virus infectious cycle.
    Res Virol. 1992 Nov-Dec;143(6):401-6 PMID: 1297175
  21. Site-directed mutations in the Sindbis virus E2 glycoprotein identify palmitoylation sites and affect virus budding.
    J Virol. 1993 May;67(5):2546-51 PMID: 8474160
  22. Basis for selective incorporation of glycoproteins into the influenza virus envelope.
    J Virol. 1993 Aug;67(8):4831-41 PMID: 8392617
  23. Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1.
    J Virol. 1993 Nov;67(11):6659-66 PMID: 7692083
  24. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
    Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122-6 PMID: 3095828
  25. A single amino acid change in the cytoplasmic domain allows the influenza virus hemagglutinin to be endocytosed through coated pits.
    Cell. 1988 Jun 3;53(5):743-52 PMID: 2897244
  26. Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant.
    J Virol. 1989 Sep;63(9):3569-78 PMID: 2547986
  27. Promoter analysis of influenza virus RNA polymerase.
    J Virol. 1989 Dec;63(12):5142-52 PMID: 2585601
  28. Amplification, expression, and packaging of foreign gene by influenza virus.
    Cell. 1989 Dec 22;59(6):1107-13 PMID: 2598262
  29. DNA sequencing with chain-terminating inhibitors.
    Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7 PMID: 271968
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1994-09-00
Pages
5748-54
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC236978
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com